Ventus Therapeutics rallies $140m Series C

Ventus Therapeutics, Inc., a biopharmaceutical company, has raised $140 million in Series C financing.

Ventus Therapeutics, Inc., a biopharmaceutical company, has raised $140 million in Series C financing. SoftBank Vision Fund 2 and RA Capital Management led the round.

Source: Press Release